LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors [Yahoo! Finance]
VUITY Reports Strong Market Performance, Setting New Benchmark in Presbyopia Care | DelveInsight [Yahoo! Finance]
LENZ Therapeutics, Inc. (NASDAQ: LENZ) had its price target raised by analysts at Citigroup Inc. from $44.00 to $47.00. They now have a "buy" rating on the stock.
LENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call Transcript [Seeking Alpha]
LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Form 8-K LENZ Therapeutics, Inc. For: Apr 04
Form S-3 LENZ Therapeutics, Inc.
Form S-3 LENZ Therapeutics, Inc.
Form POS AM LENZ Therapeutics, Inc.
Form POS AM LENZ Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.